Aclaris Therapeutics, Inc.
ACRS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001557746
No open-market purchases or sales by Aclaris Therapeutics, Inc. insiders were filed in the last 90 days; 148 institutions reported holding it in 13F filings for Q2 2026, worth $630.0M in total; no superinvestor holds it.
13F holders, Q3 2024
Institutional positions in Aclaris Therapeutics, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 81
- −16 vs. Q2 2024
- Shares held
- 50.9M
- +74.7K (+0.1%) vs. Q2 2024
- Total value
- $58.5M
- +$2.63M (+4.7%) vs. Q2 2024
- New holders
- 9
- 21 more added
- Sold out
- 25
- 28 more reduced
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ACRS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 148 | $630.0M |
| Q1 2026 | 136 | $409.4M |
| Q4 2025 | 122 | $252.1M |
| Q3 2025 | 103 | $162.8M |
| Q2 2025 | 96 | $130.4M |
| Q1 2025 | 109 | $143.8M |
| Q4 2024 | 98 | $217.0M |
| Q3 2024 | 81 | $58.5M |
| Q2 2024 | 98 | $58.1M |
| Q1 2024 | 98 | $67.5M |
| Q4 2023 | 107 | $61.4M |
| Q3 2023 | 138 | $480.0M |
| Q2 2023 | 133 | $737.2M |
| Q1 2023 | 149 | $579.3M |
| Q4 2022 | 128 | $1.04B |
| Q3 2022 | 127 | $1.00B |
| Q2 2022 | 115 | $883.3M |
| Q1 2022 | 110 | $1.02B |
| Q4 2021 | 133 | $814.9M |
| Q3 2021 | 126 | $1.02B |
| Q2 2021 | 128 | $983.4M |
| Q1 2021 | 97 | $1.14B |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Aclaris Therapeutics, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 58 | $0 | 0.00% | −4,189−98.6% | Reduced |
| Daiwa Securities Group Inc. | 248 | $0 | 0.00% | 00.0% | Unchanged |
| CWM, LLC | 1 | $0 | 0.00% | −267−99.6% | Reduced |
| Point72 (DIFC) Ltd | 92 | $106 | 0.00% | −18,227−99.5% | Reduced |
| Farther Finance Advisors, LLC | 99 | $114 | 0.00% | 00.0% | Unchanged |
| Truvestments Capital LLC | 150 | $173 | 0.00% | +150 | New |
| Nisa Investment Advisors, LLC | 318 | $366 | 0.00% | −209−39.7% | Reduced |
| Northwestern Mutual Wealth Management Co | 500 | $575 | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 1,085 | $1.00K | 0.00% | −9,081−89.3% | Reduced |
| Capital Advisors, Ltd. LLC | 454 | $1.00K | 0.00% | 00.0% | Unchanged |
| Halpern Financial, Inc. | 1,500 | $1.75K | 0.00% | 00.0% | Unchanged |
| SRS Capital Advisors, Inc. | 1,632 | $1.88K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 1,732 | $1.99K | 0.00% | +1,732 | New |
| Citigroup Inc | 2,087 | $2.40K | 0.00% | −11,384−84.5% | Reduced |
| Mirae Asset Global Investments Co., Ltd. | 2,580 | $3.02K | 0.00% | +452+21.2% | Added |
| Russell Investments Group, Ltd. | 2,765 | $3.18K | 0.00% | −785−22.1% | Reduced |
| BNP Paribas Arbitrage, SA | 3,268 | $3.76K | 0.00% | −131−3.9% | Reduced |
| Wells Fargo & Company | 4,590 | $5.28K | 0.00% | 00.0% | Unchanged |
| Cubist Systematic Strategies, LLC | 6,971 | $8.02K | 0.00% | −37,812−84.4% | Reduced |
| JPMorgan Chase & Co | 8,476 | $9.75K | 0.00% | −428−4.8% | Reduced |
| Bank of America Corp | 8,757 | $10.1K | 0.00% | +2,262+34.8% | Added |
| Two Sigma Securities, LLC | 10,740 | $12.4K | 0.00% | +10,740 | New |
| Jefferies Financial Group Inc. | 11,500 | $13.2K | 0.00% | 00.0% | Unchanged |
| Neuberger Berman Group LLC | 12,656 | $14.6K | 0.00% | 00.0% | Unchanged |
| China Universal Asset Management Co., Ltd. | 13,722 | $15.8K | 0.00% | +5,350+63.9% | Added |
| Federated Hermes, Inc. | 13,798 | $15.9K | 0.00% | +4,259+44.6% | Added |
| Catalyst Funds Management Pty Ltd | 14,000 | $16.1K | 0.00% | 00.0% | Unchanged |
| Marex Group plc | 14,400 | $16.6K | 0.00% | 00.0% | Unchanged |
| AJOVista, LLC | 17,455 | $20.1K | 0.09% | +17,455 | New |
| Algert Global LLC | 19,770 | $22.7K | 0.00% | +7,990+67.8% | Added |
| Vontobel Holding Ltd. | 20,000 | $23.0K | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 20,393 | $23.5K | 0.00% | −19,852−49.3% | Reduced |
| Tower Research Capital LLC (TRC) | 21,909 | $25.2K | 0.00% | +1,843+9.2% | Added |
| Shay Capital LLC | 27,000 | $31.1K | 0.01% | +27,000 | New |
| UBS Group AG | 31,852 | $36.6K | 0.00% | −1,939−5.7% | Reduced |
| Tudor Investment Corp Et Al | 33,183 | $38.2K | 0.00% | 00.0% | Unchanged |
| Engineers Gate Manager LP | 38,794 | $44.6K | 0.00% | −21,742−35.9% | Reduced |
| Cambridge Investment Research Advisors, Inc. | 41,873 | $48.0K | 0.00% | 00.0% | Unchanged |
| Mariner, LLC | 48,101 | $55.3K | 0.00% | +5,905+14.0% | Added |
| Point72 Asia (Singapore) Pte. Ltd. | 52,052 | $59.9K | 0.01% | −55,877−51.8% | Reduced |
| BBR Partners, LLC | 60,000 | $69.0K | 0.01% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 62,408 | $71.8K | 0.00% | −144,192−69.8% | Reduced |
| Dimensional Fund Advisors LP | 76,810 | $88.3K | 0.00% | +51+0.1% | Added |
| Jane Street Group, LLC | 82,727 | $95.1K | 0.00% | −252,282−75.3% | Reduced |
| Marquette Asset Management, LLC | 83,979 | $96.6K | 0.02% | 00.0% | Unchanged |
| ADAR1 Capital Management, LLC | 90,000 | $103.5K | 0.02% | +90,000 | New |
| Northern Trust Corp | 127,225 | $146.3K | 0.00% | −393,244−75.6% | Reduced |
| Price T Rowe Associates Inc | 139,400 | $161.0K | 0.00% | 00.0% | Unchanged |
| Squarepoint Ops LLC | 140,580 | $161.7K | 0.00% | +45,893+48.5% | Added |
| Assenagon Asset Management S.A. | 185,777 | $213.6K | 0.00% | +185,777 | New |
| State Street Corp | 188,721 | $217.0K | 0.00% | −7,900−4.0% | Reduced |
| Bridgeway Capital Management, LLC | 199,119 | $229.0K | 0.00% | +48,419+32.1% | Added |
| Gsa Capital Partners LLP | 255,032 | $293.0K | 0.02% | −81,645−24.3% | Reduced |
| Frazier Life Sciences Management, L.P. | 264,377 | $304.0K | 0.01% | 00.0% | Unchanged |
| Qube Research & Technologies Ltd | 292,845 | $336.8K | 0.00% | −647,907−68.9% | Reduced |
| Goldman Sachs Group Inc | 301,556 | $346.8K | 0.00% | −615,064−67.1% | Reduced |
| HighTower Advisors, LLC | 305,814 | $352.0K | 0.00% | −6,900−2.2% | Reduced |
| Connor, Clark & Lunn Investment Management Ltd. | 332,406 | $382.3K | 0.00% | +216,826+187.6% | Added |
| Citadel Advisors LLC | 364,567 | $419.3K | 0.00% | −510,649−58.3% | Reduced |
| Aisling Capital Management LP | 434,455 | $499.6K | 0.19% | 00.0% | Unchanged |
| Morgan Stanley | 480,773 | $552.9K | 0.00% | +294,430+158.0% | Added |
| FMR LLC | 545,972 | $627.9K | 0.00% | −143,381−20.8% | Reduced |
| Palo Alto Investors LP | 569,832 | $655.3K | 0.09% | 00.0% | Unchanged |
| Acuitas Investments, LLC | 578,139 | $664.9K | 0.30% | +114,019+24.6% | Added |
| Samsara BioCapital, LLC | 696,171 | $800.6K | 0.15% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 846,446 | $973.6K | 0.00% | +72,309+9.3% | Added |
| Two Sigma Investments, LP | 907,916 | $1.04M | 0.00% | −205,156−18.4% | Reduced |
| Jacobs Levy Equity Management, Inc | 915,509 | $1.05M | 0.00% | +915,509 | New |
| Deutsche Bank AG | 923,313 | $1.06M | 0.00% | 00.0% | Unchanged |
| Aldebaran Capital, LLC | 1,043,152 | $1.20M | 1.10% | +185,000+21.6% | Added |
| Two Sigma Advisers, LP | 1,301,500 | $1.50M | 0.00% | −135,400−9.4% | Reduced |
| Renaissance Technologies LLC | 1,370,700 | $1.58M | 0.00% | +448,500+48.6% | Added |
| BlackRock, Inc. | 1,711,797 | $1.97M | 0.00% | +1,711,797 | New |
| Trium Capital LLP | 1,912,990 | $2.20M | 1.01% | +20,940+1.1% | Added |
| Acadian Asset Management LLC | 2,078,287 | $2.39M | 0.01% | +164,838+8.6% | Added |
| Stonepine Capital Management, LLC | 2,458,873 | $2.83M | 1.79% | +531,427+27.6% | Added |
| Rock Springs Capital Management LP | 2,753,495 | $3.17M | 0.10% | 00.0% | Unchanged |
| Millennium Management LLC | 3,005,598 | $3.46M | 0.00% | −331,252−9.9% | Reduced |
| D. E. Shaw & Co., Inc. | 3,371,849 | $3.88M | 0.01% | +51,643+1.6% | Added |
| Vanguard Group Inc | 4,685,498 | $5.39M | 0.00% | −2,0530.0% | Reduced |
| BML Capital Management, LLC | 14,250,000 | $16.4M | 9.64% | +1,261,866+9.7% | Added |
| Bain Capital Life Sciences Investors, LLC | 0 | $0 | 0.00% | −1,000,000−100.0% | Sold out |
| AQR Capital Management LLC | 0 | $0 | 0.00% | −386,177−100.0% | Sold out |
| Charles Schwab Investment Management Inc | 0 | $0 | 0.00% | −260,706−100.0% | Sold out |
| Alpine Global Management, LLC | 0 | $0 | 0.00% | −177,909−100.0% | Sold out |
| Man Group plc | 0 | $0 | 0.00% | −118,459−100.0% | Sold out |
| Centiva Capital, LP | 0 | $0 | 0.00% | −117,966−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −114,806−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −82,883−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −81,005−100.0% | Sold out |
| Paloma Partners Management Co | 0 | $0 | 0.00% | −79,200−100.0% | Sold out |
| Deuterium Capital Management, LLC | 0 | $0 | 0.00% | −72,091−100.0% | Sold out |
| Rhumbline Advisers | 0 | $0 | 0.00% | −42,005−100.0% | Sold out |
| Mirae Asset Global ETFs Holdings Ltd. | 0 | $0 | 0.00% | −35,794−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −35,300−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −24,452−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −22,524−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −13,910−100.0% | Sold out |
| ProShare Advisors LLC | 0 | $0 | 0.00% | −13,701−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −11,622−100.0% | Sold out |